• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性外耳道炎

Malignant external otitis.

作者信息

Babiatzki A, Sadé J

出版信息

J Laryngol Otol. 1987 Mar;101(3):205-10. doi: 10.1017/s0022215100101549.

DOI:10.1017/s0022215100101549
PMID:3106545
Abstract

During the years 1972-1985, 50 patients with malignant external otitis (MEO) were seen in our department. All our patients complained of severe earache; they presented initially with an apparently simple external otitis, but failed to improve when the usual measures were adopted. They all presented with granulation tissue in the external ear canal, and five of our patients had multiple cranial nerve involvement. MEO is in effect a severe external otitis which, if untreated, proceeds towards an osteomyelitis of the skull base. MEO is more prevalent in the summer, when external otitis is rampant. In some years, a relatively large number of these patients appear; in others there are none. The reason for this is unknown. In Israel, the disease is more prevalent in Jews than in Arabs. Diabetes was present in 68 per cent of our patients-severe diabetes in 42 per cent, mild diabetes in 26 per cent but 32 per cent of our patients were diabetes-free. The only otological past history in our patients was of a recent traumatic insult to the external ear canal; this was the case in about 8 per cent of them. Today, the treatment of choice of this important disease is local debridement supplemented by appropriate antibiotic treatment for 6-8 weeks. This should include some semi-synthetic penicillin to which pseudomonas aeruginosa is sensitive, combined with an appropriate aminoglycoside. During the earlier years of our encounter with MEO, two of our 10 patients died of it; later on, when we learned better how to treat it, the mortality rate decreased.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1972年至1985年期间,我科共诊治了50例恶性外耳道炎(MEO)患者。所有患者均主诉耳部剧痛;最初表现为看似简单的外耳道炎,但采用常规治疗措施后未见好转。他们外耳道均有肉芽组织,其中5例患者有多条脑神经受累。实际上,MEO是一种严重的外耳道炎,若不治疗,会发展为颅底骨髓炎。MEO在夏季更为常见,此时外耳道炎高发。有些年份会出现相对较多的此类患者;有些年份则没有。原因不明。在以色列,该疾病在犹太人中比在阿拉伯人中更为普遍。我们的患者中68%患有糖尿病——42%为重度糖尿病,26%为轻度糖尿病,但32%的患者无糖尿病史。我们患者唯一的耳科既往史是近期外耳道有创伤性损伤;约8%的患者属于这种情况。如今,这种重要疾病的首选治疗方法是局部清创,并辅以适当的抗生素治疗6至8周。这应包括一些对铜绿假单胞菌敏感的半合成青霉素,联合一种适当的氨基糖苷类药物。在我们接触MEO的早期,10例患者中有2例死于该病;后来,当我们更好地了解如何治疗时,死亡率下降了。(摘要截选至250字)

相似文献

1
Malignant external otitis.恶性外耳道炎
J Laryngol Otol. 1987 Mar;101(3):205-10. doi: 10.1017/s0022215100101549.
2
Malignant external otitis versus acute external otitis.恶性外耳道炎与急性外耳道炎
J Laryngol Otol. 1987 Mar;101(3):211-5. doi: 10.1017/s0022215100101550.
3
Malignant otitis externa.恶性外耳道炎
J Craniofac Surg. 2012 Nov;23(6):1748-51. doi: 10.1097/SCS.0b013e31825e4d9a.
4
Malignant external otitis: now a medical problem.
Diabetes Care. 1980 Sep-Oct;3(5):611-4. doi: 10.2337/diacare.3.5.611.
5
[Malignant external otitis].[恶性外耳道炎]
Laryngorhinootologie. 2006 Oct;85(10):763-9; quiz 770-3. doi: 10.1055/s-2006-925441.
6
Malignant external otitis in nondiabetic patients.非糖尿病患者的恶性外耳道炎
Ann Otol Rhinol Laryngol. 1993 Nov;102(11):870-2. doi: 10.1177/000348949310201109.
7
Malignant Otitis Externa: A Novel Stratification Protocol for Predicting Treatment Outcomes.恶性外耳道炎:一种预测治疗结果的新型分层方案
Otol Neurotol. 2015 Sep;36(9):1492-8. doi: 10.1097/MAO.0000000000000839.
8
[Otitis externa maligna. Our experience].
An Otorrinolaringol Ibero Am. 1990;17(4):385-95.
9
Malignant external otitis with multiple cranial nerve involvement.伴有多组颅神经受累的恶性外耳道炎。
Am J Otol. 1979 Oct;1(2):115-20.
10
Prognostic implications of therapy for necrotizing external otitis.坏死性外耳道炎治疗的预后意义
Am J Otol. 1985 Jul;6(4):353-8.

引用本文的文献

1
Microbial spectrum, management challenges, and outcome in patients with otogenic skull base osteomyelitis.耳源性颅底骨髓炎患者的微生物谱、管理挑战及预后
Infez Med. 2024 Sep 1;32(3):340-351. doi: 10.53854/liim-3203-8. eCollection 2024.
2
Predictive value of radiologic studies for malignant otitis externa: a systematic review and meta-analysis.影像学研究对恶性外耳炎的预测价值:系统评价和荟萃分析。
Braz J Otorhinolaryngol. 2023 Jan-Feb;89(1):66-72. doi: 10.1016/j.bjorl.2021.08.011. Epub 2021 Oct 26.
3
Biannual Differences in Interest Peaks for Web Inquiries Into Ear Pain and Ear Drops: Infodemiology Study.

本文引用的文献

1
Development of PARP and Immune-Checkpoint Inhibitor Combinations.PARP 与免疫检查点抑制剂联合治疗的发展。
Cancer Res. 2018 Dec 15;78(24):6717-6725. doi: 10.1158/0008-5472.CAN-18-2652. Epub 2018 Nov 29.
2
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.他拉唑帕尼治疗携带有胚系 BRCA 突变的晚期乳腺癌患者。
N Engl J Med. 2018 Aug 23;379(8):753-763. doi: 10.1056/NEJMoa1802905. Epub 2018 Aug 15.
3
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
耳痛和滴耳液网络查询兴趣高峰的半年差异:信息流行病学研究。
J Med Internet Res. 2021 Jun 24;23(6):e28328. doi: 10.2196/28328.
4
From Uncommon Infection to Multi-Cranial Palsy: Malignant External Otitis Insights.从罕见感染到多颅神经麻痹:恶性外耳道炎的见解
Dose Response. 2020 Dec 17;18(4):1559325820963910. doi: 10.1177/1559325820963910. eCollection 2020 Oct-Dec.
5
Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre.恶性(坏死性)外耳炎:一家高压氧中心的经验。
Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1881-1887. doi: 10.1007/s00405-019-05396-7. Epub 2019 Jun 4.
6
Temporomandibular joint disorder from skull-base osteomyelitis: a case report.颅底骨髓炎所致颞下颌关节紊乱:一例报告
Maxillofac Plast Reconstr Surg. 2015 Oct 31;37(1):39. doi: 10.1186/s40902-015-0041-1. eCollection 2015 Dec.
7
Malignant otitis external-our experience.恶性外耳道炎——我们的经验
Indian J Otolaryngol Head Neck Surg. 2002 Apr;54(2):132-5. doi: 10.1007/BF02968732.
8
Malignant external otitis in an immunodeficient infant. a case report & review of literature.免疫缺陷婴儿的恶性外耳道炎。病例报告及文献复习。
Indian J Otolaryngol Head Neck Surg. 2000 Oct;52(4):386-9. doi: 10.1007/BF02991488.
9
Skull based osteomyelitis due to postsurgery malignant otitis externa presenting as stroke.手术后恶性外耳道炎所致颅骨骨髓炎表现为中风。
BMJ Case Rep. 2011 May 24;2011:bcr0220113908. doi: 10.1136/bcr.02.2011.3908.
10
Granulation tissue concentrations of ofloxacin after oral administration in invasive external otitis.
Eur Arch Otorhinolaryngol. 1993;250 Suppl 1:S15-7. doi: 10.1007/BF02540111.
尼拉帕利对比安慰剂治疗复发性卵巢癌患者的生活质量(ENGOT-OV16/NOVA):一项双盲、III 期、随机对照临床试验的结果。
Lancet Oncol. 2018 Aug;19(8):1117-1125. doi: 10.1016/S1470-2045(18)30333-4. Epub 2018 Jul 17.
4
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.BRCA1 或 BRCA2 突变 29700 个家系的世界性研究中的突变谱。
Hum Mutat. 2018 May;39(5):593-620. doi: 10.1002/humu.23406. Epub 2018 Mar 12.
5
Simultaneous detection of genetic and copy number alterations in genes.同时检测基因中的遗传改变和拷贝数改变。
Oncotarget. 2017 Dec 6;8(70):114463-114473. doi: 10.18632/oncotarget.22962. eCollection 2017 Dec 29.
6
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.通过多基因panel 检测优化选择的遗传性乳腺癌/卵巢癌家族中与风险相关的突变的识别。
Cancer Med. 2018 Jan;7(1):46-55. doi: 10.1002/cam4.1251. Epub 2017 Dec 22.
7
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.芦卡帕利维持治疗铂类化疗后缓解的复发性卵巢癌(ARIEL3):一项随机、双盲、安慰剂对照、III 期临床试验。
Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12.
8
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
9
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.奥拉帕利治疗携种系 BRCA 突变的转移性乳腺癌患者。
N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4.
10
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.聚腺苷二磷酸核糖聚合酶抑制剂增强复制应激,导致 MYCN 依赖性神经母细胞瘤有丝分裂灾难。
Oncogene. 2017 Aug 17;36(33):4682-4691. doi: 10.1038/onc.2017.40. Epub 2017 Apr 10.